Free shipping on all orders over $ 500

GSK 690 Hydrochloride

Cat. No. M10826
GSK 690 Hydrochloride Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine-specific demethylase 1 (LSD1),Kd The value is 9 nM,IC50 The value is 37 nM.

Chemical Information
Molecular Weight 369.46
Formula C24H23N3O
CAS Number 2101305-84-2
Solubility (25°C) DMSO ≥ 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Andrei Bondar, et al. Exp Ther Med. Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)

[2] Pierre Amarenco, et al. JAMA Neurol. Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial

[3] Dejan Juric, et al. JAMA Oncol. Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial

[4] Daniel P Mould, et al. Bioorg Med Chem Lett. Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1

[5] Deepali Bang, et al. Cancer Discov. GSK-3α promotes oncogenic KRAS function in pancreatic cancer via TAK1-TAB stabilization and regulation of noncanonical NF-κB

Related Histone demethylase Products
INCB059872

INCB059872 is a potent, orally active, selective and irreversible inhibitor of lysine-specific demethylase 1 (LSD1) in myeloid leukemia.

KDM2A/7A-IN-1

KDM2A/7A-IN-1 is a first-in-class, selective, cell-permeable inhibitor of the histone lysine demethylase KDM2A/7A, with an IC50 value of 0.16 μM for KDM2A, 75-fold more selective than other JmjC lysine demethylases, and with no effect on methyltransferases or histone acetyltransferases. KDM2A was 75 times more selective than other JmjC lysine demethylases and had no effect on methyltransferases and histone acetyltransferases.

NCD38 TFA

NCD38 TFA is a LSD1-selective inhibitor.

LSD1-IN-26

LSD1-IN-26 is a potent LSD1 inhibitor, with an IC50 of 25.3 nM.

JMJD6-IN-1

JMJD6-IN-1 is a JMJD6 inhibitor, with an inhibition rate of 82% at 10 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK 690 Hydrochloride supplier, Histone demethylase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.